NCT01599559: Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma

Sponsor: International Extranodal Lymphoma Study Group (IELSG). Phase: NA. Conditions: Primary Mediastinal B-cell Lymphoma